Cooperated Pipeline Product
| Number | Product | CAS | Indication | Patent | |
|---|---|---|---|---|---|
| 1 | Finerenone | 1050477-31-0 | Diabetic Chronic Kidney Disease | 2028-02 |
|
| 2 | Venetoclax | 1257044-40-8 | Chronic Lymphoid Leukemia | 2030-11 |
|
| 3 | Vericiguat | 1350653-20-1 | Chronic Heart Failure | 2031-05 |
|
| 4 | Fezolinetant | 1629229-37-3 | Vasomotor Symptoms | 2034-03 |
|
Self-Developed Products
| Number | Product | CAS | Indication | Status | |
|---|---|---|---|---|---|
| 1 | Cabozantinib | 849217-68-1 | Advanced Renal Cell Carcinoma/Hepatocellular Carcinoma | PV / FDA(DMF # 039757) |
|
| 2 | Cytisine | 485-35-8 | Smoking Cessation | PV / FDA(DMF # 039649) |
|
| 3 | 7-Ethyl-10-hydroxycamptothecin | 130144-34-2 | Triple-negative Breast Cancer | PV / FDA (DMF # 039576) |
|
| 4 | Resmetirom | 920509-32-6 | Noncirrhotic Nonalcoholic Steatohepatitis | Pilot / FDA(DMF # 040872) |
|
| 5 | Darolutamide | 1297538-32-9 | Non-metastatic Castration-Resistant Prostatic Cancer | R&D |
|
| 6 | Indigo Carmine | 860-22-0 | Diagnostic Dye | Pilot |
|
| 7 | Osimertinib | 1421373-66-1 | EGFR-mutated non-small Cell lung cancer | R&D |
|
| 8 | Abemaciclib | 1231929-97-7 | Breast Cancer | R&D |
|
| 9 | Berberine Hydrochloride (Synthesis) | 633-65-8 | Anti-infection | R&D |
|
| 10 | Conjugated Estrogens (Synthesis) | 12126-59-9 | Estrogen Supplements | R&D |
|
